Related Experiment Video
Updated: Sep 13, 2025
07:50
Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
Published on: April 18, 2025
403
Charting New Paths in Cancer Research: Insights from the Frontiers in Cancer Science Conference 2024.
Giang Le Minh1, Sasidharan Swarnalatha Lucky2, Shazib Pervaiz1,3
1Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Cancer Research
|August 1, 2025
Summary
Leading cancer experts met to discuss treatment resistance, tumor microenvironment, and immunotherapies. Advances in spatial transcriptomics and AI promise personalized, cost-effective cancer care.
Area of Science:
- Oncology
- Cancer Biology
- Immunology
Background:
- The 16th annual Frontiers in Cancer Science conference gathered experts to address critical challenges in oncology.
- Key themes included understanding and overcoming cancer treatment resistance, exploring metabolic vulnerabilities, and modulating the tumor microenvironment.
Purpose of the Study:
- To synthesize recent advancements in cancer research and therapeutic strategies.
- To explore novel technologies and computational approaches for personalized cancer care.
Main Methods:
- Discussions and presentations by leading cancer researchers.
- Focus on mechanisms of treatment resistance and innovative targeting strategies.
- Exploration of metabolic plasticity, tumor microenvironment modulation, and immunotherapies.
- Highlighting spatial transcriptomics and artificial intelligence (AI) in cancer research.
Main Results:
- Identified key vulnerabilities in cancer metabolism and resistance mechanisms.
- Showcased advancements in immunotherapies and engineered immune cells for cancer treatment.
- Demonstrated the utility of spatial transcriptomics in understanding tumor heterogeneity.
- Emphasized the potential of AI and machine learning in optimizing cancer therapy and prognostication.
Conclusions:
- Collective insights highlight rapid progress in cancer biology and treatment.
- Translational potential of new discoveries for effective clinical interventions.
- Significant steps toward addressing cancer complexity and improving global patient care.
Related Concept Videos
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
01:21Cancer Survival Analysis
456
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
456
01:30Cancer Vaccines
514
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
514
02:40Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K